Literature DB >> 24136106

Diffuse osteosclerosis in a patient with prostate cancer.

N Ustün1, I Ustün, T Ozgür, N Atci, F Aydoğan, A T Sümbül, A D Turhanoğlu.   

Abstract

A 61-year-old man was referred to our outpatient clinic because of severe bilateral upper leg pain for 1 year. On admission, the patient had anemia and a high serum alkaline phosphatase level. Lumbar and femoral neck T-scores were +10.5 and +9.6, respectively. His radius 33 % T-score was -2.8. Plain radiographs of the patient's pelvis, spine, and long bones revealed osteosclerosis. The patient had previously undergone a prostate biopsy, which showed prostate adenocarcinoma (Gleason score 3 + 4). The patient's total and free prostate-specific antigen were very high. According to previous records, the patient did not have anemia, and his serum alkaline phosphatase (ALP) level was normal. An abdominal radiograph taken 2 years earlier revealed a normal spine and pelvic bone. Bone scintigraphy yielded nontypical findings for prostate cancer metastasis. Computed tomography of the patient's thorax and abdomen showed heterogeneous sclerotic areas in all bones consistent with prostate cancer metastasis. A bone marrow biopsy disclosed disseminated carcinomatosis of bone marrow in association with prostate cancer. Clinicians should be aware of the possibility of prostate malignancy as a cause of high bone mineral density (BMD), even in the absence of typical localized findings on plain radiographs.

Entities:  

Mesh:

Year:  2013        PMID: 24136106     DOI: 10.1007/s00198-013-2545-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  22 in total

Review 1.  Natural history and treatment of bone complications in prostate cancer.

Authors:  Fred Saad; Noel Clarke; Marc Colombel
Journal:  Eur Urol       Date:  2006-01-06       Impact factor: 20.096

2.  LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST.

Authors:  Mikhail V Semenov; Xi He
Journal:  J Biol Chem       Date:  2006-10-19       Impact factor: 5.157

Review 3.  Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis.

Authors:  Lauren L Ihde; Deborah M Forrester; Christopher J Gottsegen; Sulabha Masih; Dakshesh B Patel; Linda A Vachon; Eric A White; George R Matcuk
Journal:  Radiographics       Date:  2011 Nov-Dec       Impact factor: 5.333

Review 4.  The central role of osteoblasts in the metastasis of prostate cancer.

Authors:  Michel B Choueiri; Shi-Ming Tu; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

5.  Case 150: Van Buchem disease (hyperostosis corticalis generalisata).

Authors:  Martina Wengenroth; Gergely Vasvari; Philipp A Federspil; Johanna Mair; Peter Schneider; Christoph Stippich
Journal:  Radiology       Date:  2009-10       Impact factor: 11.105

6.  Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers.

Authors:  Antoon H van Lierop; Neveen A T Hamdy; Martje E van Egmond; Egbert Bakker; Freek G Dikkers; Socrates E Papapoulos
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

7.  Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activity.

Authors:  Carlos Hernandez-Cassis; Claudia K Vogel; Tatiana P Hernandez; Michael J Econs; Melitza Iglesias; Antonio Iglesias; Silvina Levis; Bernard A Roos; Guy A Howard; Antonio Iglesias Gamarra
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 8.  Pathogenesis of osteoblastic bone metastases from prostate cancer.

Authors:  Toni Ibrahim; Emanuela Flamini; Laura Mercatali; Emanuele Sacanna; Patrizia Serra; Dino Amadori
Journal:  Cancer       Date:  2010-03-15       Impact factor: 6.860

9.  Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not "normal".

Authors:  Michael P Whyte
Journal:  J Clin Densitom       Date:  2005       Impact factor: 2.963

Review 10.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

View more
  1 in total

1.  Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.

Authors:  Núria Guañabens; Steven Mumm; Laia Gifre; Silvia Ruiz-Gaspà; Jennifer L Demertzis; Marina Stolina; Deborah V Novack; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2016-05-09       Impact factor: 6.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.